WAIVER AND ASSIGNMENT OF REGISTRATION RIGHTS AND VOTING AGREEMENTWaiver and Assignment of Registration Rights and Voting Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • Delaware
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionThis WAIVER AND ASSIGNMENT OF REGISTRATION RIGHTS AND VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 22, 2020, by and among GSK Finance (No.3) plc, a public limited company incorporated under the laws of England and Wales (“GSK Finance”), Glaxo Group Limited (“GGL”) and Theravance Biopharma, Inc., a Cayman Islands exempted company (the “Company” and with GSK Finance and GGL, each a “Party”).
COOPERATION AGREEMENTCooperation Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionThis COOPERATION AGREEMENT (this “Agreement”) is entered into as of June 22, 2020, by and among Theravance BIOPHARMA, Inc. (the “Company”), GlaxoSmithKline plc (“GSK”) and GSK FINANCE (NO.3) PLC (the “Issuer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 22, 2020, is by and among THERAVANCE BIOPHARMA, INC., a Cayman Islands exempted company (the “Company”), GLAXOSMITHKLINE PLC, a public limited company incorporated under the laws of England and Wales, with registered number 03888792 (“GSK”), and GSK FINANCE (NO.3) PLC, a public limited company incorporated under the laws of England and Wales, with registered number 12615561 (“GSK Issuer”).
GSK Finance (No.3) plcIndenture • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionTHIS INDENTURE, dated as of June 22, 2020, is among GSK Finance (No.3) plc, a public limited company incorporated under the laws of England and Wales (the “Issuer”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as Guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, as trustee (in such capacity, the “Trustee”), principal paying agent (in such capacity, the “Principal Paying Agent”), transfer agent (in such capacity, the “Transfer Agent”), principal exchange agent (in such capacity, the “Principal Exchange Agent”) and registrar (in such capacity, the “Registrar”).